Cisplatin and Birth control - a phase IV clinical study of FDA data

Summary:

Birth control is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Bleomycin Sulfate, and have Cervix carcinoma.

The phase IV clinical study analyzes which people have Birth control when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Birth control?

Birth control is found to be associated with 872 drugs and 1,645 conditions by eHealthMe. Check the latest studies of Birth control.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 04, 2026

92,672 people reported to have side effects when taking Cisplatin.
Among them, 32 people (0.03%) have Birth control.

Among these 32 people:

How long have people been on Cisplatin when they have Birth control? *

What is the gender of people who have Birth control when taking Cisplatin? *

female: 84.38 %
male: 15.62 %

What is the age of people who have Birth control when taking Cisplatin? *

What are other drugs people take besides Cisplatin? *

What are other side effects people have besides Birth control? *

Normal Newborn: 13 people, 40.62%
Live Birth: 5 people, 15.62%
Premature Delivery: 2 people, 6.25%
Death: 2 people, 6.25%
Nausea (feeling of having an urge to vomit): 2 people, 6.25%
Beta 2 Microglobulin Increased: 2 people, 6.25%
Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid): 2 people, 6.25%
Pre-Eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman): 2 people, 6.25%
Premature Baby: 2 people, 6.25%
Deafness Transitory (deafness temporary): 2 people, 6.25%

What are the existing conditions these people have? *

Cervix Carcinoma (cancer of cervix): 9 people, 28.12%
Ovarian Neoplasm (tumour of ovary): 3 people, 9.38%
Lymphoma (cancer that begins in immune system cells): 2 people, 6.25%
Stress And Anxiety: 2 people, 6.25%
Ovarian Germ Cell Cancer: 2 people, 6.25%
Non-Small Cell Lung Cancer Stage Iiib: 2 people, 6.25%
High Blood Pressure: 2 people, 6.25%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 6.25%
Headache (pain in head): 1 person, 3.12%
Adrenocortical Carcinoma (adrenal cortex cancer): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and have Birth control?

- Check whether Birth control is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cisplatin:

Cisplatin (92,837 reports)

Birth control treatments and more:

Birth control (288,761 reports)

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Birth control:

Birth control (872 drugs)

Browse all the conditions that are associated with Birth control:

Birth control (1,645 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.